Boehringer Ingelheim announced new 340B claims data requirements for Tennessee covered entities.

BI Asks Tennessee Contract Pharmacies to Report Claims Data Ahead of New State Law, BMS Updates Contract Pharmacy Restrictions

May 30, 2025 Shannon Young, Associate Editor/Senior Writer Views

Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!